Top Markets
Coin of the day
Purple Biotech Ltd. Purple Biotech Ltd.

Purple Biotech Ltd.

PPBT
Peringkat dalam Saham #40642
Purple Biotech Ltd., a clinical-stage company, is focused on creating therapies... Purple Biotech Ltd., a clinical-stage company, is focused on creating therapies for cancer patients in the United States, specifically addressing challenges like tumor immune evasion and drug resistance. Its diverse oncology pipeline includes CM24, a humanized monoclonal antibody that targets and blocks carcinoembryonic antigen related cell adhesion molecule 1 (CEACAM1). Currently in Phase 2 clinical trials, CM24 is being investigated as a combination therapy with anti-PD-1 checkpoint inhibitors for treating pancreatic ductal adenocarcinoma. Another candidate is NT219, a small molecule compound in Phase 1/2 clinical trials, which functions by inhibiting insulin receptor substrate 1 and 2 (IRS1/2) and signal transducer and activator of transcription (STAT). This compound is being developed for recurrent and/or metastatic squamous cell carcinoma of the head and neck, or colorectal adenocarcinoma. Furthermore, IM1240, a multi-valent antibody designed to activate an anti-tumoral immune response against 5T4-positive tumors, is in its preclinical stage. The company has established significant collaborations, including an agreement with Bristol Myers Squibb Company for Phase 2 clinical trials to assess CM24 in combination with the PD-1 inhibitor nivolumab and chemotherapy, as well as a partnership with Mor Research Applications. Formerly known as Kitov Pharma Ltd., the company adopted the name Purple Biotech Ltd. in December 2020 and is headquartered in Rehovot, Israel.
Harga Saham
$0.00323826
Terakhir disinkronkan: 2026-08-12
Kapitalisasi Pasar
$104.81K
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-70.42%
Negara
IL
Perdagangan Purple Biotech Ltd. (PPBT)

Kategori

Riwayat harga saham Purple Biotech Ltd. (PPBT)
Harga penutupan tertinggi: $0.00 pada 2026-08-01

Harga penutupan terendah: $66.99K pada 2002-08-01
Riwayat harga saham Purple Biotech Ltd. dari 2002 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) 0.00%
2025 -81.67%
2024 -77.97%
2023 -42.38%
2022 -58.58%
2021 -1.91%
2020 -42.76%
2019 -27.25%
2018 -53.94%
2017 -34.07%
2016 -2.83%
2015 -56.33%
2014 -90.72%
2013 19.75%
2012 -27.68%
2011 -56.00%
2010 -33.42%
2009 12.56%
2008 -95.78%
2007 7.52%
2006 9.91%
2005 47.91%
2004 -83.15%
2003 -65.07%
2002 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$517.18 30.63%
US
$857.76 32.66%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE